In a recent conversation with PharmaBoardroom, Nathalie Moll gives an insight into the work underway across the European pharmaceutical industry to battle COVID-19 in terms of supporting organisations on the ground, ensuring the supply of medicines, and working on the research and development of treatments, vaccines, and diagnostics.
EFPIA Director General also outlines the vital importance of stakeholder collaboration to drive positive outcomes during the pandemic and raises the possibility of a more inter-connected and collaborative industry emerging out of the crisis.
Read more
This virtual event provided an opportunity to hear about and ask questions on the search for vaccines against COVID-19....
Read more
About the EFPIA newsletter
The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.